{"transactions":[{"id":772179,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-05-19T21:17:20.000Z","date":"2026-04-30","kind":"purchase","planned":false,"acquired":true,"shares":1971,"price":2.71,"value":5341.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares adjusted to correct immaterial errors."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares adjusted to correct immaterial errors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares adjusted to correct immaterial errors."}],"balance_after":7481,"source":{"system":"sec-edgar","filing":"0000897069-26-001154","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706926001154/form4a.xml","form_type":"4/A","original_submission_date":"2026-05-01"}},{"id":795774,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-05-01T20:34:34.000Z","date":"2026-04-30","kind":"purchase","planned":false,"acquired":true,"shares":1986,"price":2.69,"value":5342.34,"ownership":{"direct":true},"balance_after":7496,"source":{"system":"sec-edgar","filing":"0000897069-26-001000","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706926001000/form4.xml","form_type":"4"}},{"id":805676,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-04-17T20:50:19.000Z","date":"2026-04-15","kind":"purchase","planned":false,"acquired":true,"shares":1799,"price":2.97,"value":5343.03,"ownership":{"direct":true},"balance_after":5510,"source":{"system":"sec-edgar","filing":"0000897069-26-000904","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706926000904/form4.xml","form_type":"4"}},{"id":822933,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-04-01T21:08:25.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":2107,"price":2.535,"value":5341.245,"ownership":{"direct":true},"balance_after":3711,"source":{"system":"sec-edgar","filing":"0000897069-26-000743","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706926000743/form4.xml","form_type":"4"}},{"id":919496,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-04T22:04:07.000Z","date":"2026-01-01","kind":"exercise","planned":false,"acquired":false,"shares":249,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Distribution of vested restricted shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Distribution of vested restricted shares."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":249},"source":{"system":"sec-edgar","filing":"0000897069-26-000218","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706926000218/form4.xml","form_type":"4"}},{"id":919495,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-02-04T22:04:07.000Z","date":"2026-01-01","kind":"exercise","planned":false,"acquired":true,"shares":249,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of vested restricted shares."}],"balance_after":1604,"source":{"system":"sec-edgar","filing":"0000897069-26-000218","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706926000218/form4.xml","form_type":"4"}},{"id":1024693,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-10-03T20:29:49.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":288000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."}],"balance_after":288000,"derivative":{"exercise_price":0.198,"underlying":"Common Stock","underlying_shares":288000},"source":{"system":"sec-edgar","filing":"0000897069-25-001549","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706925001549/form4.xml","form_type":"4"}},{"id":1024692,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-03T20:29:49.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."}],"balance_after":96000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":96000},"source":{"system":"sec-edgar","filing":"0000897069-25-001549","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706925001549/form4.xml","form_type":"4"}},{"id":1080658,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-07-28T20:32:43.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":1659185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan (\"Omnibus Plan\"), of which 1,638,778 shares are subject to stockholder approval of the revised Omnibus Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028."}],"balance_after":1672087,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1659185},"source":{"system":"sec-edgar","filing":"0000897069-25-001219","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706925001219/form4.xml","form_type":"4"}},{"id":1173348,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-04-11T21:17:49.000Z","date":"2025-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3311,"price":0.412,"value":1364.132,"ownership":{"direct":true},"balance_after":33626,"source":{"system":"sec-edgar","filing":"0000897069-25-000789","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706925000789/form4.xml","form_type":"4"}},{"id":1173347,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-04-11T21:17:49.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":true,"shares":15059,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of vested restricted shares."}],"balance_after":36937,"source":{"system":"sec-edgar","filing":"0000897069-25-000789","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706925000789/form4.xml","form_type":"4"}},{"id":1442980,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2024-08-02T21:34:41.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting upon the achievement of certain performance goals."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting upon the achievement of certain performance goals."}],"balance_after":27961,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":404},"source":{"system":"sec-edgar","filing":"0000897069-24-001615","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706924001615/form4.xml","form_type":"4"}},{"id":1442979,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2024-08-02T21:34:41.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting upon the achievement of certain performance goals."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting upon the achievement of certain performance goals."}],"balance_after":27557,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":404},"source":{"system":"sec-edgar","filing":"0000897069-24-001615","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706924001615/form4.xml","form_type":"4"}},{"id":1442978,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2024-08-02T21:34:41.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":2425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2025, and one-thirty-sixth each month thereafter until fully vested on January 1, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2025, and one-thirty-sixth each month thereafter until fully vested on January 1, 2027."}],"balance_after":27153,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2425},"source":{"system":"sec-edgar","filing":"0000897069-24-001615","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706924001615/form4.xml","form_type":"4"}},{"id":1442977,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2024-08-02T21:34:41.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":3233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on January 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on January 1, 2025."}],"balance_after":24728,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3233},"source":{"system":"sec-edgar","filing":"0000897069-24-001615","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706924001615/form4.xml","form_type":"4"}},{"id":1442976,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-08-02T21:34:41.000Z","date":"2024-07-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":225,"price":1.71,"value":384.75,"ownership":{"direct":true},"balance_after":21878,"source":{"system":"sec-edgar","filing":"0000897069-24-001615","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706924001615/form4.xml","form_type":"4"}},{"id":1442975,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-08-02T21:34:41.000Z","date":"2024-07-10","kind":"exercise","planned":false,"acquired":true,"shares":644,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of vested restricted shares."}],"balance_after":22103,"source":{"system":"sec-edgar","filing":"0000897069-24-001615","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706924001615/form4.xml","form_type":"4"}},{"id":1442974,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-08-02T21:34:41.000Z","date":"2024-04-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":368,"price":2.79,"value":1026.72,"ownership":{"direct":true},"balance_after":21459,"source":{"system":"sec-edgar","filing":"0000897069-24-001615","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706924001615/form4.xml","form_type":"4"}},{"id":1442973,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-08-02T21:34:41.000Z","date":"2024-04-05","kind":"exercise","planned":false,"acquired":true,"shares":1675,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of vested restricted shares."}],"balance_after":21827,"source":{"system":"sec-edgar","filing":"0000897069-24-001615","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706924001615/form4.xml","form_type":"4"}},{"id":1542610,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2024-04-12T20:52:51.000Z","date":"2024-01-01","kind":"exercise","planned":false,"acquired":false,"shares":1675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Distribution of vested restricted shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Distribution of vested restricted shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective on January 22, 2024, Processa Pharmaceuticals, Inc. effected a 20 to 1 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":22139,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1675},"source":{"system":"sec-edgar","filing":"0000897069-24-000919","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706924000919/form4.xml","form_type":"4"}},{"id":1542609,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-04-12T20:52:51.000Z","date":"2024-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":368,"price":2.79,"value":1026.72,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective on January 22, 2024, Processa Pharmaceuticals, Inc. effected a 20 to 1 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":21458,"source":{"system":"sec-edgar","filing":"0000897069-24-000919","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706924000919/form4.xml","form_type":"4"}},{"id":1542608,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-04-12T20:52:51.000Z","date":"2024-01-01","kind":"exercise","planned":false,"acquired":true,"shares":1675,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of vested restricted shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective on January 22, 2024, Processa Pharmaceuticals, Inc. effected a 20 to 1 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":21826,"source":{"system":"sec-edgar","filing":"0000897069-24-000919","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706924000919/form4.xml","form_type":"4"}},{"id":2068210,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-04T22:38:37.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":48490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock units represents a contingent right to receive one share of the lssuers common stock, following its vesting of one-third on 01/01/24; 01/01/25 and 01/01/26, upon the earlier of termination of employment; the third anniversary of the award date; a change in control, or the reporting persons death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock units represents a contingent right to receive one share of the lssuers common stock, following its vesting of one-third on 01/01/24; 01/01/25 and 01/01/26, upon the earlier of termination of employment; the third anniversary of the award date; a change in control, or the reporting persons death."}],"balance_after":480475,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":48490},"source":{"system":"sec-edgar","filing":"0001567619-23-000320","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000156761923000320/doc1.xml","form_type":"4"}},{"id":2068209,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-04T22:38:37.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":75907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock units represents a contingent right to receive one share of stock, following its vesting on 01/01/24, upon the earlier of termination of employment; the third anniversary of the award date; a change in control, or the reporting persons death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock units represents a contingent right to receive one share of stock, following its vesting on 01/01/24, upon the earlier of termination of employment; the third anniversary of the award date; a change in control, or the reporting persons death."}],"balance_after":431985,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":75907},"source":{"system":"sec-edgar","filing":"0001567619-23-000320","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000156761923000320/doc1.xml","form_type":"4"}},{"id":2068208,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-04T22:38:37.000Z","date":"2022-12-31","kind":"grant","acquired":true,"shares":13851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":356073,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13851},"source":{"system":"sec-edgar","filing":"0001567619-23-000320","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000156761923000320/doc1.xml","form_type":"4"}},{"id":2147525,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2022-10-03T20:55:34.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":13850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":342227,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13850},"source":{"system":"sec-edgar","filing":"0001567619-22-018061","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000156761922018061/doc1.xml","form_type":"4"}},{"id":2190960,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-08-09T20:25:08.000Z","date":"2022-08-05","kind":"exercise","acquired":true,"shares":7601,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Vesting of time-based restricted shares."}],"balance_after":403019,"source":{"system":"sec-edgar","filing":"0001567619-22-015305","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000156761922015305/doc1.xml","form_type":"4"}},{"id":2214870,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2022-07-05T21:41:37.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":25611,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":328377,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":25611},"source":{"system":"sec-edgar","filing":"0001567619-22-013685","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000156761922013685/doc1.xml","form_type":"4"}},{"id":2299476,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-11T21:58:25.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":247841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted Stock Units (RSUs) vest upon achievement of certain performance goals. The grant of 136,632 RSUs are subject to shareholder approval of the Issuer's 2019 Omnibus Incentive Plan (the \"Plan\") to increase the authorized shares under the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Restricted Stock Units (RSUs) vest upon achievement of certain performance goals. The grant of 136,632 RSUs are subject to shareholder approval of the Issuer's 2019 Omnibus Incentive Plan (the \"Plan\") to increase the authorized shares under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The previous filing understated this number. This new total accurately reflects the cumulative total of Restricted Stock Units for the reporting person."}],"balance_after":302766,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":247841},"source":{"system":"sec-edgar","filing":"0001567619-22-008369","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000156761922008369/doc1.xml","form_type":"4"}},{"id":2308535,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-04T21:52:30.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":10715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":37781,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10715},"source":{"system":"sec-edgar","filing":"0001567619-22-007998","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000156761922007998/doc1.xml","form_type":"4"}},{"id":2308534,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-04T21:52:30.000Z","date":"2021-11-01","kind":"grant","acquired":true,"shares":4286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":27066,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4286},"source":{"system":"sec-edgar","filing":"0001567619-22-007998","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000156761922007998/doc1.xml","form_type":"4"}},{"id":2441716,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-06T22:28:35.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":6722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Amendment is being filed to correct the balance in Box 9 - this should have reflected a cumulative balance."}],"balance_after":22780,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6722},"source":{"system":"sec-edgar","filing":"0001567619-22-000779","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000156761922000779/doc1.xml","form_type":"4/A","original_submission_date":"2022-01-04"}},{"id":2441715,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-06T20:58:40.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":6024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Amendment is being filed to correct the balance in Box 9 - this should have reflected a cumulative balance."}],"balance_after":16058,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6024},"source":{"system":"sec-edgar","filing":"0001567619-22-000710","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000156761922000710/doc1.xml","form_type":"4/A","original_submission_date":"2021-10-04"}},{"id":2449713,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-04T22:32:44.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":6722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":6722,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6722},"source":{"system":"sec-edgar","filing":"0001567619-22-000304","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000156761922000304/doc1.xml","form_type":"4"}},{"id":2552224,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2021-10-04T20:49:58.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":6024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":6024,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6024},"source":{"system":"sec-edgar","filing":"0001567619-21-017833","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000156761921017833/doc1.xml","form_type":"4"}},{"id":2610162,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-08-09T20:40:19.000Z","date":"2021-08-05","kind":"grant","acquired":true,"shares":7601,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Vesting of time-based restricted shares."}],"balance_after":395418,"source":{"system":"sec-edgar","filing":"0001567619-21-014751","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000156761921014751/doc1.xml","form_type":"4"}},{"id":2637090,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-09T20:42:16.000Z","date":"2021-07-08","kind":"grant","acquired":true,"shares":1907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":10034,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10034},"source":{"system":"sec-edgar","filing":"0001567619-21-013191","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000156761921013191/doc1.xml","form_type":"4"}},{"id":2637089,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-09T20:42:16.000Z","date":"2021-07-08","kind":"grant","acquired":true,"shares":12858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vest upon achievement of certain performance goals."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vest upon achievement of certain performance goals."}],"balance_after":12858,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12858},"source":{"system":"sec-edgar","filing":"0001567619-21-013191","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000156761921013191/doc1.xml","form_type":"4"}},{"id":2637088,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-09T20:42:16.000Z","date":"2021-07-08","kind":"grant","acquired":true,"shares":8572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in two equal installments beginning July 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units vest in two equal installments beginning July 1, 2022."}],"balance_after":8572,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8572},"source":{"system":"sec-edgar","filing":"0001567619-21-013191","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000156761921013191/doc1.xml","form_type":"4"}},{"id":2674109,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2021-06-10T21:13:13.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":8127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":8127,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8127},"source":{"system":"sec-edgar","filing":"0001567619-21-011986","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000156761921011986/doc1.xml","form_type":"4"}}]}